Biomarkers of Progression after HIV Acute/Early Infection: Nothing Compares to CD4+ T-cell Count?
AbstractProgression of HIV infection is variable among individuals, and definition disease progression biomarkers is still needed. Here, we aimed to categorize the predictive potential of several variables using feature selection methods and decision trees. A total of seventy-five treatment-naïve subjects were enrolled during acute/early HIV infection. CD4+ T-cell counts (CD4TC) and viral load (VL) levels were determined at enrollment and for one year. Immune activation, HIV-specific immune response, Human Leukocyte Antigen (HLA) and C-C chemokine receptor type 5 (CCR5) genotypes, and plasma levels of 39 cytokines were determined. Data were analyzed by machine learning and non-parametric methods. Variable hierarchization was performed by Weka correlation-based feature selection and J48 decision tree. Plasma interleukin (IL)-10, interferon gamma-induced protein (IP)-10, soluble IL-2 receptor alpha (sIL-2Rα) and tumor necrosis factor alpha (TNF-α) levels correlated directly with baseline VL, whereas IL-2, TNF-α, fibroblast growth factor (FGF)-2 and macrophage inflammatory protein (MIP)-1β correlated directly with CD4+ T-cell activation (p < 0.05). However, none of these cytokines had good predictive values to distinguish “progressors” from “non-progressors”. Similarly, immune activation, HIV-specific immune responses and HLA/CCR5 genotypes had low discrimination power. Baseline CD4TC was the most potent discerning variable with a cut-off of 438 cells/μL (accuracy = 0.93, κ-Cohen = 0.85). Limited discerning power of the other factors might be related to frequency, variability and/or sampling time. Future studies based on decision trees to identify biomarkers of post-treatment control are warrantied. View Full-Text
Scifeed alert for new publicationsNever miss any articles matching your research from any publisher
- Get alerts for new papers matching your research
- Find out the new papers from selected authors
- Updated daily for 49'000+ journals and 6000+ publishers
- Define your Scifeed now
Turk, G.; Ghiglione, Y.; Hormanstorfer, M.; Laufer, N.; Coloccini, R.; Salido, J.; Trifone, C.; Ruiz, M.J.; Falivene, J.; Holgado, M.P.; Caruso, M.P.; Figueroa, M.I.; Salomón, H.; Giavedoni, L.D.; Pando, M.Á.; Gherardi, M.M.; Rabinovich, R.D.; Pury, P.A.; Sued, O. Biomarkers of Progression after HIV Acute/Early Infection: Nothing Compares to CD4+ T-cell Count? Viruses 2018, 10, 34.
Turk G, Ghiglione Y, Hormanstorfer M, Laufer N, Coloccini R, Salido J, Trifone C, Ruiz MJ, Falivene J, Holgado MP, Caruso MP, Figueroa MI, Salomón H, Giavedoni LD, Pando MÁ, Gherardi MM, Rabinovich RD, Pury PA, Sued O. Biomarkers of Progression after HIV Acute/Early Infection: Nothing Compares to CD4+ T-cell Count? Viruses. 2018; 10(1):34.Chicago/Turabian Style
Turk, Gabriela; Ghiglione, Yanina; Hormanstorfer, Macarena; Laufer, Natalia; Coloccini, Romina; Salido, Jimena; Trifone, César; Ruiz, María J.; Falivene, Juliana; Holgado, María P.; Caruso, María P.; Figueroa, María I.; Salomón, Horacio; Giavedoni, Luis D.; Pando, María Á.; Gherardi, María M.; Rabinovich, Roberto D.; Pury, Pedro A.; Sued, Omar. 2018. "Biomarkers of Progression after HIV Acute/Early Infection: Nothing Compares to CD4+ T-cell Count?" Viruses 10, no. 1: 34.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.